Search research articles
Contact Us
Filters
Showing results (111-120 of 159) with videos related to
Page
of 16
Sort By:
Biotechnology Journal
|
November 11, 2021
Mechanistic discoveries and simulation-guided assay optimization of portable hormone biosensors with cell-free protein synthesis
John Porter Hunt, Jackelyn Galiardi, Tyler J Free, et al.
European Journal of Endocrinology
|
October 26, 2020
Response to 'Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasia'
Robin Michelet, Johanna Melin, Zinnia P Parra-Guillen, et al.
European Journal of Endocrinology
|
July 5, 2020
Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children
Robin Michelet, Johanna Melin, Zinnia P Parra-Guillen, et al.
Blood Advances
|
October 15, 2021
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro
Zhi-Jian Liu, Emoke Deschmann, Haley E Ramsey, et al.
Anemia
|
August 28, 2012
Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial
John Porter, Donald K Bowden, Marina Economou, et al.
Analytical Chemistry
|
May 24, 2013
Identification of differential protein binding affinities in an atropisomeric pharmaceutical compound by noncovalent mass spectrometry, equilibrium dialysis, and nuclear magnetic resonance
Hannah J Maple, Rachel A Garlish, Ian Whitcombe, et al.
American Journal of Hematology
|
May 13, 2022
An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results
Yong-Rong Lai, Maria Domenica Cappellini, Yesim Aydinok, et al.
Leukemia Research
|
July 9, 2011
Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox
Florian Nolte, Emanuele Angelucci, Photis Beris, et al.
Journal of Neurology
|
April 18, 2021
Neuropsychological and neuroimaging characteristics of classical superficial siderosis
Edgar Chan, Yezen Sammaraiee, Gargi Banerjee, et al.
Journal of Medicinal Chemistry
|
December 14, 2011
Automated protein-ligand interaction screening by mass spectrometry
Hannah J Maple, Rachel A Garlish, Laura Rigau-Roca, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 159) with videos related to
Sort By:
Page
of 16
Biotechnology Journal
|
November 11, 2021
Mechanistic discoveries and simulation-guided assay optimization of portable hormone biosensors with cell-free protein synthesis
John Porter Hunt, Jackelyn Galiardi, Tyler J Free, et al.
European Journal of Endocrinology
|
October 26, 2020
Response to 'Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasia'
Robin Michelet, Johanna Melin, Zinnia P Parra-Guillen, et al.
European Journal of Endocrinology
|
July 5, 2020
Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children
Robin Michelet, Johanna Melin, Zinnia P Parra-Guillen, et al.
Blood Advances
|
October 15, 2021
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro
Zhi-Jian Liu, Emoke Deschmann, Haley E Ramsey, et al.
Anemia
|
August 28, 2012
Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial
John Porter, Donald K Bowden, Marina Economou, et al.
Analytical Chemistry
|
May 24, 2013
Identification of differential protein binding affinities in an atropisomeric pharmaceutical compound by noncovalent mass spectrometry, equilibrium dialysis, and nuclear magnetic resonance
Hannah J Maple, Rachel A Garlish, Ian Whitcombe, et al.
American Journal of Hematology
|
May 13, 2022
An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results
Yong-Rong Lai, Maria Domenica Cappellini, Yesim Aydinok, et al.
Leukemia Research
|
July 9, 2011
Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox
Florian Nolte, Emanuele Angelucci, Photis Beris, et al.
Journal of Neurology
|
April 18, 2021
Neuropsychological and neuroimaging characteristics of classical superficial siderosis
Edgar Chan, Yezen Sammaraiee, Gargi Banerjee, et al.
Journal of Medicinal Chemistry
|
December 14, 2011
Automated protein-ligand interaction screening by mass spectrometry
Hannah J Maple, Rachel A Garlish, Laura Rigau-Roca, et al.
Page
of 16